THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA
Online ISSN : 1349-9149
Print ISSN : 0285-4945
ISSN-L : 0285-4945
Symposium (2)
The Clinical Usefulness of Tramadol
Koji KAWAI
Author information
JOURNAL FREE ACCESS

2013 Volume 33 Issue 1 Pages 041-050

Details
Abstract

  Tramadol is an opioid analgesic which is prescribed worldwide. Hydrochloride oral and injectable formulations have been approved for cancer pain and postoperative pain (injection only) in Japan. In addition, tablets combining tramadol with acetaminophen have been administrated for non-cancer pain and post-tooth-extraction pain. Tramadol acts as a μ-opioid receptor agonist and inhibits the reuptake of serotonin and norepinephrine. Regarding the management of cancer pain, it is placed on the second step of the World Health Organization analgesic ladder. Tramadol is gradually coming into use as a relatively safe and less addictive drug among opioid analgesics for both cancer and non-cancer pain.

Content from these authors
© 2013 by The Japan Society for Clinical Anesthesia
Previous article Next article
feedback
Top